ArticleBreast (Edinburgh, Scotland)2026
Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.
Fatih Kemik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.